new indications for glp 1 drugs GLP-1 are changing more than the number on the scale. From diabetes and obesity to heart, kidney, and metabolic health — this story is getting bigger fast. ❤️ Swipe to learn New GLP-1 Guidelines for Type

PLoS One 3:e1944, PMID: 18398470 Berk M, Johansson S, Wray NR, Williams L, Olsson C, Haavik J, Bjerkeset O (2011) Glutamate cysteine ligase (GCL) and self reported depression: an association study from the HUNT

Safety of Compounded Medications

Thus, the FDA has approved these two low-intensity DOACs for this indication

Lipotropic injections are generally administered in areas that contain significant subcutaneous fatty tissues, e.g., the arm, thigh, buttocks, or abdomen

What are the treatment steps

Critically, SV2A correlated with MRS dACC glutamate content (r = 0.55) in healthy controls and in patients in keeping with the predominance of glutamate synapses in cortex and suggesting that MRS glutamate is partly reflective of the presynaptic glutamate pool